Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamara Ialongo

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Toxicon : Official Journal of the International Society on Toxinology|August 12, 2015
Clinical differences between botulinum neurotoxin type A and BAnna Rita Bentivoglio, Alessandra Del Grande, Martina Petracca, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2004
Phenotypic characterization of DYT13 primary torsion dystoniaAnna Rita Bentivoglio, Tamara Ialongo, M Fiorella Contarino, et al.
Disability and Rehabilitation|April 25, 2007
Computerized gait analysis of botulinum toxin treatment in children with cerebral palsyManuela Galli, Veronica Cimolin, Enza Maria Valente, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Phenotypic variability of DYT1-PTD: does the clinical spectrum include psychogenic dystonia?Anna Rita Bentivoglio, Mario Loi, Enza M Valente, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 25, 2011
Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's diseaseArianna Guidubaldi, Alfonso Fasano, Tamara Ialongo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2014
Phenotypic variability of PINK1 expression: 12 Years' clinical follow-up of two Italian familiesLucia Ricciardi, Simona Petrucci, Arianna Guidubaldi, et al.
Annals of Neurology|September 7, 2004
PINK1 mutations are associated with sporadic early-onset parkinsonismEnza Maria Valente, Sergio Salvi, Tamara Ialongo, et al.
Human Mutation|December 13, 2006
Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrumRoberta Marongiu, Francesco Brancati, Angelo Antonini, et al.
Journal of Neurology|September 6, 2022
Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-upMartina Petracca, Maria Rita Lo Monaco, Tamara Ialongo, et al.
Journal of Neurology|June 28, 2008
Subclinical sensory abnormalities in unaffected PINK1 heterozygotesMirta Fiorio, Enza Maria Valente, Mattia Gambarin, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Toxicon : Official Journal of the International Society on Toxinology|August 12, 2015
Clinical differences between botulinum neurotoxin type A and BAnna Rita Bentivoglio, Alessandra Del Grande, Martina Petracca, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2004
Phenotypic characterization of DYT13 primary torsion dystoniaAnna Rita Bentivoglio, Tamara Ialongo, M Fiorella Contarino, et al.
Disability and Rehabilitation|April 25, 2007
Computerized gait analysis of botulinum toxin treatment in children with cerebral palsyManuela Galli, Veronica Cimolin, Enza Maria Valente, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Phenotypic variability of DYT1-PTD: does the clinical spectrum include psychogenic dystonia?Anna Rita Bentivoglio, Mario Loi, Enza M Valente, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 25, 2011
Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's diseaseArianna Guidubaldi, Alfonso Fasano, Tamara Ialongo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2014
Phenotypic variability of PINK1 expression: 12 Years' clinical follow-up of two Italian familiesLucia Ricciardi, Simona Petrucci, Arianna Guidubaldi, et al.
Annals of Neurology|September 7, 2004
PINK1 mutations are associated with sporadic early-onset parkinsonismEnza Maria Valente, Sergio Salvi, Tamara Ialongo, et al.
Human Mutation|December 13, 2006
Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrumRoberta Marongiu, Francesco Brancati, Angelo Antonini, et al.
Journal of Neurology|September 6, 2022
Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-upMartina Petracca, Maria Rita Lo Monaco, Tamara Ialongo, et al.
Journal of Neurology|June 28, 2008
Subclinical sensory abnormalities in unaffected PINK1 heterozygotesMirta Fiorio, Enza Maria Valente, Mattia Gambarin, et al.
Pageof 2